Skip to main content
logo
Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.240
-0.235 (-6.76%)
At close: Feb 5, 2026, 4:00 PM EST
3.350
+0.110 (3.40%)
Pre-market: Feb 6, 2026, 5:12 AM EST

Prime Medicine Revenue

Prime Medicine had revenue of $1.23M in the quarter ending September 30, 2025, with 486.12% growth. This brings the company's revenue in the last twelve months to $5.98M, up 647.13% year-over-year. In the year 2024, Prime Medicine had annual revenue of $2.98M.

Revenue (ttm)
$5.98M
Revenue Growth
+647.13%
P/S Ratio
74.35
Revenue / Employee
$27,930
Employees
214
Market Cap
573.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.98M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 20205.21M--
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MiMedx Group393.44M
Rigel Pharmaceuticals282.08M
CorMedix214.30M
Gyre Therapeutics107.27M
Kura Oncology104.03M
Fulcrum Therapeutics80.00M
MeiraGTx Holdings27.42M
Altimmune20.00K
Revenue Rankings

PRME News

More News